NOTABLE LABS LTD

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NTBLQ and buy or sell other stocks, ETFs, and their options commission-free!

About NTBLQ

Notable Labs Ltd. is a clinical-stage platform therapeutics company that develops predictive medicines for patients with cancer. Through its proprietary Predictive Medicines Platform, the firm predicts whether or not that patient is likely to respond to that specific therapeutic. 

CEO
Kaile A. Zagger
CEOKaile A. Zagger
Employees
Employees
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2000
Founded2000
Employees
Employees

NTBLQ Key Statistics

Market cap
965.95
Market cap965.95
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.89
Average volume1.89
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.001
52 Week high$0.001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

NOTABLE LABS LTD(NTBLQ) stock is priced at $0.00, giving the company a market capitalization of 965.95.

On 2026-04-12, NOTABLE LABS LTD(NTBLQ) stock opened at —, reached a high of —, and a low of —.

NOTABLE LABS LTD(NTBLQ) shares are trading with a volume of 0, against a daily average of 1.89.

In the last year, NOTABLE LABS LTD(NTBLQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.

In the last year, NOTABLE LABS LTD(NTBLQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.

People also own

Based on the portfolios of people who own NTBLQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.